Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis

A limited number of therapeutic strategies are currently available for patients with inflammatory bowel disease (IBD). In particular, the maintenance therapy after remission in Crohn's disease (CD) is not satisfactory and new approaches are needed. Interleukin-10 gene-deficient (IL-10(–/–)) mic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Matsuda, C, Ito, T, Song, J, Mizushima, T, Tamagawa, H, Kai, Y, Hamanaka, Y, Inoue, M, Nishida, T, Matsuda, H, Sawa, Y
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2007
Assuntos:
Animal Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1868878/
https://ncbi.nlm.nih.gov/pubmed/17437423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2007.03345.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
A carregar...

Registos relacionados